1. Maraviroc decreases CCL8-mediated migration of CCR5+ regulatory T cells and reduces metastatic tumor growth in the lungs. (2nd June 2016) Authors: Halvorsen, E. C.; Hamilton, M. J.; Young, A.; Wadsworth, B. J.; LePard, N. E.; Lee, H. N.; Firmino, N.; Collier, J. L.; Bennewith, K. L. Journal: Oncoimmunology Issue: Volume 5:Number 6(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗